These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 22921458

  • 1. Experimental modeling of recombinant tissue plasminogen activator effects after ischemic stroke.
    El Amki M, Lerouet D, Coqueran B, Curis E, Orset C, Vivien D, Plotkine M, Marchand-Leroux C, Margaill I.
    Exp Neurol; 2012 Dec; 238(2):138-44. PubMed ID: 22921458
    [Abstract] [Full Text] [Related]

  • 2. Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke.
    Romanos E, Planas AM, Amaro S, Chamorro A.
    J Cereb Blood Flow Metab; 2007 Jan; 27(1):14-20. PubMed ID: 16596120
    [Abstract] [Full Text] [Related]

  • 3. Combined therapy with PJ34, a poly(ADP-ribose)polymerase inhibitor, reduces tissue plasminogen activator-induced hemorrhagic transformations in cerebral ischemia in mice.
    Haddad M, Beray-Berthat V, Coqueran B, Plotkine M, Marchand-Leroux C, Margaill I.
    Fundam Clin Pharmacol; 2013 Aug; 27(4):393-401. PubMed ID: 22436003
    [Abstract] [Full Text] [Related]

  • 4. Application of albumin prior to delayed thrombolysis reduces brain edema and blood brain barrier permeability in an embolic stroke model.
    Lu HT, Zhao JG, Li MH, Li YD.
    Brain Res; 2012 Feb 15; 1438():75-84. PubMed ID: 22227456
    [Abstract] [Full Text] [Related]

  • 5. Hematoma expansion in experimental intracerebral hemorrhage is not altered by peracute treatment with recombinant tissue plasminogen activator.
    Pfeilschifter W, Kashefiolasl S, Lauer A, Steinmetz H, Foerch C.
    Neuroscience; 2013 Oct 10; 250():181-8. PubMed ID: 23856067
    [Abstract] [Full Text] [Related]

  • 6. Serum S100B indicates successful combination treatment with recombinant tissue plasminogen activator and MK-801 in a rat model of embolic stroke.
    Tanaka Y, Marumo T, Omura T, Yoshida S.
    Brain Res; 2007 Jun 18; 1154():194-9. PubMed ID: 17475227
    [Abstract] [Full Text] [Related]

  • 7. Reduced brain infarct volume and improved neurological outcome by inhibition of the NR2B subunit of NMDA receptors by using CP101,606-27 alone and in combination with rt-PA in a thromboembolic stroke model in rats.
    Yang Y, Li Q, Yang T, Hussain M, Shuaib A.
    J Neurosurg; 2003 Feb 18; 98(2):397-403. PubMed ID: 12593629
    [Abstract] [Full Text] [Related]

  • 8. Combined treatment with recombinant tissue plasminogen activator and dexamethasone phosphate-containing liposomes improves neurological outcome and restricts lesion progression after embolic stroke in rats.
    Tiebosch IA, Crielaard BJ, Bouts MJ, Zwartbol R, Salas-Perdomo A, Lammers T, Planas AM, Storm G, Dijkhuizen RM.
    J Neurochem; 2012 Nov 18; 123 Suppl 2():65-74. PubMed ID: 23050644
    [Abstract] [Full Text] [Related]

  • 9. Improved Reperfusion and Vasculoprotection by the Poly(ADP-Ribose)Polymerase Inhibitor PJ34 After Stroke and Thrombolysis in Mice.
    El Amki M, Lerouet D, Garraud M, Teng F, Beray-Berthat V, Coqueran B, Barsacq B, Abbou C, Palmier B, Marchand-Leroux C, Margaill I.
    Mol Neurobiol; 2018 Dec 18; 55(12):9156-9168. PubMed ID: 29651748
    [Abstract] [Full Text] [Related]

  • 10. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
    Schwammenthal Y, Drescher MJ, Merzeliak O, Tsabari R, Bruk B, Feibel M, Hoffman C, Bakon M, Rotstein Z, Chapman J, Tanne D.
    Isr Med Assoc J; 2004 Feb 18; 6(2):70-4. PubMed ID: 14986460
    [Abstract] [Full Text] [Related]

  • 11. Prevention of rt-PA induced blood-brain barrier component degradation by the poly(ADP-ribose)polymerase inhibitor PJ34 after ischemic stroke in mice.
    Teng F, Beray-Berthat V, Coqueran B, Lesbats C, Kuntz M, Palmier B, Garraud M, Bedfert C, Slane N, Bérézowski V, Szeremeta F, Hachani J, Scherman D, Plotkine M, Doan BT, Marchand-Leroux C, Margaill I.
    Exp Neurol; 2013 Oct 18; 248():416-28. PubMed ID: 23876515
    [Abstract] [Full Text] [Related]

  • 12. FK-506 extended the therapeutic time window for thrombolysis without increasing the risk of hemorrhagic transformation in an embolic rat stroke model.
    Okubo S, Igarashi H, Kanamatsu T, Hasegawa D, Orima H, Katayama Y.
    Brain Res; 2007 Apr 27; 1143():221-7. PubMed ID: 17316578
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic time window of tacrolimus (FK506) in a nonhuman primate stroke model: comparison with tissue plasminogen activator.
    Furuichi Y, Maeda M, Matsuoka N, Mutoh S, Yanagihara T.
    Exp Neurol; 2007 Mar 27; 204(1):138-46. PubMed ID: 17169359
    [Abstract] [Full Text] [Related]

  • 14. rt-PA causes a dose-dependent increase in the extravasation of cellular and non-cellular blood elements after focal cerebral ischemia.
    Burggraf D, Martens HK, Dichgans M, Hamann GF.
    Brain Res; 2007 Aug 20; 1164():55-62. PubMed ID: 17644075
    [Abstract] [Full Text] [Related]

  • 15. Epigallocatechin Gallate Extends the Therapeutic Window of Recombinant Tissue Plasminogen Activator Treatment in Ischemic Rats.
    You YP.
    J Stroke Cerebrovasc Dis; 2016 Apr 20; 25(4):990-7. PubMed ID: 26851971
    [Abstract] [Full Text] [Related]

  • 16. Predictors of major neurological improvement after intravenous thrombolysis in acute ischemic stroke: a hospital-based study from south India.
    Boddu DB, Srinivasarao Bandaru VC, Reddy PG, Madhusudan M, Rukmini MK, Suryaprabha T, Jabeen SA, Suvarna A, Jayalakshmi SS, Meena AK, Borgohain R, Kaul S.
    Neurol India; 2010 Apr 20; 58(3):403-6. PubMed ID: 20644268
    [Abstract] [Full Text] [Related]

  • 17. Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke.
    Alonso de Leciñana M, Gutiérrez M, Roda JM, Carceller F, Díez-Tejedor E.
    J Neurol Sci; 2006 Sep 25; 247(2):121-9. PubMed ID: 16797595
    [Abstract] [Full Text] [Related]

  • 18. Baicalin Attenuates Blood-Brain Barrier Disruption and Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke Rats with Delayed t-PA Treatment: Involvement of ONOO--MMP-9 Pathway.
    Chen H, Guan B, Chen X, Chen X, Li C, Qiu J, Yang D, Liu KJ, Qi S, Shen J.
    Transl Stroke Res; 2018 Oct 25; 9(5):515-529. PubMed ID: 29275501
    [Abstract] [Full Text] [Related]

  • 19. LDL receptor blockade reduces mortality in a mouse model of ischaemic stroke without improving tissue-type plasminogen activator-induced brain haemorrhage: towards pre-clinical simulation of symptomatic ICH.
    Niego B, Broughton BRS, Ho H, Sobey CG, Medcalf RL.
    Fluids Barriers CNS; 2017 Nov 21; 14(1):33. PubMed ID: 29157263
    [Abstract] [Full Text] [Related]

  • 20. Protection of cerebral microvasculature after moderate hypothermia following experimental focal cerebral ischemia in mice.
    Burk J, Burggraf D, Vosko M, Dichgans M, Hamann GF.
    Brain Res; 2008 Aug 21; 1226():248-55. PubMed ID: 18586014
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.